Roles of lncRNAs in cancer: Focusing on angiogenesis

Life Sci. 2020 Jul 1:252:117647. doi: 10.1016/j.lfs.2020.117647. Epub 2020 Apr 8.

Abstract

Approximately 98% of the human genome consists of non-coding sequences that are classified into two classes by size: small non-coding RNAs (≤200 nucleotides) and long non-coding RNAs (≥200 nucleotides). Long non-coding RNAs (lncRNAs) are involved in various cellular events and act as guides, signals, decoys, and dynamic scaffolds. Due to their oncogenic and tumor suppressive roles, lncRNAs are important in cancer development and growth. LncRNAs play their roles by modulating cancer hallmarks, including DNA damage, metastasis, immune escape, cell stemness, drug resistance, metabolic reprogramming, and angiogenesis. Angiogenesis is vital for solid tumors which guarantees their growth beyond 2 mm3. Tumor angiogenesis is a complex process and is regulated through interaction between pro-angiogenic and anti-angiogenic factors within the tumor microenvironment. There are accumulating evidence that different lncRNAs regulate tumor angiogenesis. In this paper, we described the functions and mechanisms of lncRNAs in tumor angiogenesis.

Keywords: Angiogenesis; Cancer; Long non-coding RNAs (lncRNAs); Metastasis; Tumor microenvironment.

Publication types

  • Review

MeSH terms

  • DNA Damage / genetics
  • Drug Resistance, Neoplasm
  • Genome, Human
  • Humans
  • Neoplasms / genetics
  • Neoplasms / pathology*
  • Neovascularization, Pathologic / genetics
  • Neovascularization, Pathologic / pathology*
  • RNA, Long Noncoding / genetics*
  • Tumor Microenvironment / genetics

Substances

  • RNA, Long Noncoding